Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†

Eduardo Schiffer(University of Geneva), Olivier Rosmorduc(Assistance Publique – Hôpitaux de Paris)
Hepatology
January 19, 2005
Cited by 335


Related Papers